Data shown in Table 5 revealed that Ki67 mRNA expression was an independent predictor for neoadjuvant chemotherapy in locally advanced breast cancer (OR, 4.385; CI, 1.206–286.53; p = 0.036). This evidence concerns the gene MKI67 and breast cancer.